T. Lesimple, M. D. de Miguel, Cristophe Le Tourneau, M. Ponz-Sarvisé, M. Sablin, D. Benito, B. Hanna, Henry Chang, Xin Wei, Marta Ocejo Garcia, P. Lardelli, Tania Sánchez, J. Palau, Z. Nikolova, E. Calvo
{"title":"P033: CC-95775,一种用于晚期实体瘤(STs)患者的可逆口服溴域和外端(BET)抑制剂:1期研究结果","authors":"T. Lesimple, M. D. de Miguel, Cristophe Le Tourneau, M. Ponz-Sarvisé, M. Sablin, D. Benito, B. Hanna, Henry Chang, Xin Wei, Marta Ocejo Garcia, P. Lardelli, Tania Sánchez, J. Palau, Z. Nikolova, E. Calvo","doi":"10.1158/1535-7163.targ-21-p033","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20348,"journal":{"name":"Poster Presentations - Proffered Abstracts","volume":"23 22","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract P033: CC-95775, a reversible, oral bromodomain and extra-terminal (BET) inhibitor in patients with advanced solid tumors (STs): Results of a phase 1 study\",\"authors\":\"T. Lesimple, M. D. de Miguel, Cristophe Le Tourneau, M. Ponz-Sarvisé, M. Sablin, D. Benito, B. Hanna, Henry Chang, Xin Wei, Marta Ocejo Garcia, P. Lardelli, Tania Sánchez, J. Palau, Z. Nikolova, E. Calvo\",\"doi\":\"10.1158/1535-7163.targ-21-p033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20348,\"journal\":{\"name\":\"Poster Presentations - Proffered Abstracts\",\"volume\":\"23 22\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Poster Presentations - Proffered Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1535-7163.targ-21-p033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster Presentations - Proffered Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1535-7163.targ-21-p033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract P033: CC-95775, a reversible, oral bromodomain and extra-terminal (BET) inhibitor in patients with advanced solid tumors (STs): Results of a phase 1 study